4 ways protein monitoring could change the way we stay healthy

VariantFormer is the first deep learning model characterizing cross-tissue gene expression by bridging sequence-based modeling across genomes with population-based modeling across personalized genomes.

scLDM, a deep generative AI model of transcriptomics, generates realistic single-cell data to accelerate virtual cell research.

We are entering a third revolution in immunology with the ability to solve some of the hardest problems in disease, says Aly Khan, Biohub’s senior director of artificial intelligence.

The Rare As One Cycle 2 Impact Report highlights how patient communities are accelerating research and reshaping the rare disease landscape.

Core to this collaboration is an effort to scale biological data processing to petabytes of data spanning billions of cellular observations.

To accelerate biological research with AI, we’ll need specific, shared datasets, says the head of data science at Biohub.

Our community-driven benchmarking suite standardizes biological AI model evaluation to accelerate scientific discovery.

Sjoukje van der Stegen, a Biohub group lead, is working to understand immune cell development with hopes of expanding access to immunotherapies

A new perspective paper explores how continuous protein monitoring could help us detect, manage and prevent disease before symptoms appear.